King Christy M, Johnston James S, Ofili Kene, Tam Maylynn, Palefsky Joel, Da Costa Maria, Mathur Yasha, Barbosa Peter
California School of Podiatric Medicine at Samuel Merritt University, Oakland, CA. Dr. King is now with Kaiser Permanente Oakland, Oakland, CA. Dr. Johnston is now with Orthopedic Surgery Specialists, Aberdeen, SD. Dr. Ofili is now with San Francisco Bay Area Foot and Ankle Residency Program, 2nd year. Dr. Tam is now with Kaiser Permanente Vallejo, Vallejo, CA.
J Am Podiatr Med Assoc. 2014 Mar;104(2):141-6. doi: 10.7547/0003-0538-104.2.141.
Although an increased prevalence of plantar verrucae has been associated with human immunodeficiency virus (HIV) infection, human papillomavirus (HPV) typing studies have not been published about this patient population. We sought to determine the prevalence of HPV types in plantar verrucae of HIV-positive (HIV+) and HIV-negative (HIV-) individuals.
Thirty-nine plantar verruca lesions in 17 individuals were examined. Nine participants were HIV+ and eight were HIV-. Detection of HPV was performed by polymerase chain reaction using two sets of primers: MY09/MY11. The type of HPV was determined by hybridization to 38 different HPV types. Clinical types of verrucae were correlated to the HPV strain identified in each lesion.
Of the 39 plantar verruca samples, 38 typed to HPV-2, HPV-27, and HPV-57 strains in HIV+ and HIV- individuals. Specifically, a large proportion of the samples from HIV- individuals typed as HPV-27 (87.5%), and HPV-2 was the predominant type identified in HIV+ individuals (50%). No rare or atypical HPV types were found in either group. We identified HPV-2 and HPV-27 in 96% of verruca plantaris clinical type. Mosaic warts typed to HPV-27 and HPV-57, and 80% of punctate verrucae typed to HPV-57.
This study presents an increased prevalence of HPV-2, HPV-27, and HPV-57 in plantar verrucae in this study population and provides insight into the occurrence of these types in HIV+ and HIV- individuals.
虽然足底疣患病率的增加与人类免疫缺陷病毒(HIV)感染有关,但尚未发表关于该患者群体的人乳头瘤病毒(HPV)分型研究。我们试图确定HIV阳性(HIV+)和HIV阴性(HIV-)个体足底疣中HPV类型的患病率。
对17名个体的39个足底疣病变进行了检查。9名参与者为HIV+,8名参与者为HIV-。使用两组引物(MY09/MY11)通过聚合酶链反应进行HPV检测。通过与38种不同HPV类型杂交确定HPV类型。将疣的临床类型与每个病变中鉴定出的HPV毒株相关联。
在39个足底疣样本中,38个在HIV+和HIV-个体中分型为HPV-2、HPV-27和HPV-57毒株。具体而言,HIV-个体的大部分样本分型为HPV-27(87.5%),HPV-2是在HIV+个体中鉴定出的主要类型(50%)。两组均未发现罕见或非典型HPV类型。我们在96%的跖疣临床类型中鉴定出HPV-2和HPV-27。镶嵌疣分型为HPV-27和HPV-57,80%的点状疣分型为HPV-57。
本研究表明,在该研究人群的足底疣中,HPV-2、HPV-27和HPV-57的患病率增加,并深入了解了这些类型在HIV+和HIV-个体中的发生情况。